𝔖 Bobbio Scriptorium
✦   LIBER   ✦

0891 Comparison of the safety and efficacy of botulinum toxin type-A and tizanidine in the treatment of cervical dystonia


Book ID
123076004
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
128 KB
Volume
238
Category
Article
ISSN
0022-510X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Comparison of treatment of tardive dysto
✍ Dr. Allison Brashear; Walter T. Ambrosius; George J. Eckert; Eric R. Siemers πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 337 KB

To compare clinical parameters of patients treated with botulinum toxin type A (BTX) for treatment of idiopathic cervical dystonia (ICD) and for tardive cervical dystonia (TCD), we studied 156 patients (149 with ICD and 7 with TCD) who were treated with serial injections of BTX over 5 years. We hypo

Efficacy and safety of repeated doses of
✍ Stewart A. Factor; Eric S. Molho; Sharon Evans; Paul J. Feustel πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 107 KB

## Abstract Efficacy of botulinum toxin type B (BoNT B) for the treatment of type A‐resistant (AR) and non‐A‐resistant (NAR) cervical dystonia (CD) has been demonstrated in several single injection studies. There is little data available on long‐term therapy with repeated injection sessions and it

Long-term safety, efficacy, dosing, and
✍ Brian Berman; Lauren Seeberger; Rajeev Kumar πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 64 KB

## Abstract Short‐term studies of cervical dystonia (CD) have demonstrated botulinum toxin type B (Bot B) to be safe and efficacious at doses of 5,000 to 10,000 units, but few long‐term studies have been published and the safety and efficacy of higher doses has not been established. Additionally, t